{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:16:55Z","timestamp":1772198215522,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]},{"name":"Ricardo Palma University","award":["ACU N0 2619-2019"],"award-info":[{"award-number":["ACU N0 2619-2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Limited evidence exists on the population attributable fraction (PAF) of cancer cases and deaths in Latin America. In Peru several studies have been published regarding the PAF of various risk factors and their associated diseases. The objective of this study was to estimate the fraction of cancer cases and deaths attributable to potentially modifiable risk factors in Peru in 2018, before the COVID-19 pandemic in the population of 15 years old and older.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An ecological study was conducted using the prevalence of exposure of the Peruvian population to modifiable risk factors for cancer, the relative risk associated with each factor, and the number of cancer cases and deaths in 2018 as inputs. We used the Parkin formula with a Montecarlo statistical simulation model to calculate the PAF and confidence intervals. The number of new cancer cases and deaths attributed to each risk factor was determined by multiplying the number of cases and deaths in each gender by the PAF of each risk factor.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Findings<\/jats:title>\n                <jats:p>In Peru, 38.5% of new cases (34.5% in men and 42% in women) and 43.4% of cancer-related deaths (43.4% in men and 43.4% in women) were attributable to modifiable risk factors. The number of cancers attributable was 25,308 (10,439 in men and 14,869 in women) and the number of deaths attributable to cancer was 14,839 (6,953 in men and 7,886 in women). The predominant modifiable risk factors contributing to the highest number of cases and deaths were HPV infection (4,563 cases, 2,409 deaths), current tobacco use (3,348 cases, 2,180 deaths), and <jats:italic>helicobacter pylori<\/jats:italic> infection (2,677 cases, 1,873 deaths). Among the risk factors, oncogenic infections constituted the group with the highest PAF (16.6% for cases, 19.2% for deaths) followed by other unhealthy lifestyle factors (14.2% for cases, 16.7% for deaths), tobacco (7.2% for cases, 7.2% for deaths) and ultraviolet radiation (0.5% for cases, 0.3% for deaths).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prior to the COVID-19 pandemic, 38.5% of cancer cases and 43.4% of cancer-related deaths in Peru were linked to modifiable risk factors in the population of 15 years old and older. Most preventable cancer cases and deaths were related to oncogenic infections, primarily caused by HPV and <jats:italic>helicobacter pylori<\/jats:italic>, followed by tobacco and obesity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12219-4","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:02:29Z","timestamp":1713189749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Proportion of cancer cases and deaths attributable to potentially modifiable risk factors in Peru"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5592-0504","authenticated-orcid":false,"given":"Jhony A.","family":"De La Cruz-Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-7811","authenticated-orcid":false,"given":"Willy","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-6856","authenticated-orcid":false,"given":"Willer","family":"Chanduv\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-4391","authenticated-orcid":false,"given":"Lucy E.","family":"Correa-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7442-2060","authenticated-orcid":false,"given":"Nadia","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-6501","authenticated-orcid":false,"given":"Joan","family":"Loayza-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-8641","authenticated-orcid":false,"given":"Irene","family":"Tami-Maury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-888X","authenticated-orcid":false,"given":"Diego","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"10","key":"12219_CR1","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S1470-2045(17)30377-7","volume":"18","author":"M Pi\u00f1eros","year":"2017","unstructured":"Pi\u00f1eros M, Ramos W, Antoni S, Abriata G, Medina LE, Miranda JJ, et al. Cancer patterns, trends, and transitions in Peru: a regional perspective. Lancet Oncol. 2017;18(10):e573\u201386. https:\/\/doi.org\/10.1016\/S1470-2045(17)30377-7","journal-title":"Lancet Oncol"},{"key":"12219_CR2","doi-asserted-by":"crossref","unstructured":"Ramos W, Guerrero N, Medina J, Guerrero P. An\u00e1lisis de la situaci\u00f3n del C\u00e1ncer en el Per\u00fa, 2018. Lima: Ministerio de Salud del Per\u00fa; 2022. https:\/\/www.dge.gob.pe\/epipublic\/uploads\/asis\/asis_2020_27_120833.pdf","DOI":"10.25176\/RFMH.v20i1.2704"},{"key":"12219_CR3","unstructured":"International Agency for Reasearch on Cancer. Cancer Today. Lyon, IARC; 2018. https:\/\/gco.iarc.fr\/today\/home. Accessed 20 Dec 2013."},{"key":"12219_CR4","unstructured":"Centro Nacional de Epidemiolog\u00eda, Prevenci\u00f3n y Control de Enfermedades, Ministerio de Salud del Per\u00fa. Carga de Enfermedad en el Per\u00fa. Estimaci\u00f3n de los a\u00f1os de vida saludable perdidos 2016. Lima: Ministerio de Salud del Per\u00fa. 2019. https:\/\/www.dge.gob.pe\/portal\/docs\/tools\/Cargaenfermedad2016.pdf. Accessed 20 Dec 2013."},{"issue":"3","key":"12219_CR5","first-page":"1","volume":"15","author":"W Valdez","year":"2011","unstructured":"Valdez W, Miranda J, Ramos W. State of the epidemiologic transition in Peru during 1990 and 2006. Rev Peru Epidemiol. 2011;15(3):1\u20135.","journal-title":"Rev Peru Epidemiol"},{"issue":"S1","key":"12219_CR6","first-page":"e06","volume":"18","author":"W Ramos","year":"2014","unstructured":"Ramos W, Venegas D, Honorio H, Pesantes J, Arrasco J, Yagui M. Non-communicable diseases: effect of major transitions and social determinants. Rev Peru Epidemiol. 2014;18(S1):e06.","journal-title":"Rev Peru Epidemiol"},{"key":"12219_CR7","volume-title":"Prevenci\u00f3n Y Control De Enfermedades, Ministerio De Salud Del Per\u00fa. An\u00e1lisis De Situaci\u00f3n De Salud Del Per\u00fa, 2021","author":"Centro Nacional de Epidemiolog\u00eda","year":"2023","unstructured":"Centro Nacional de Epidemiolog\u00eda. Prevenci\u00f3n Y Control De Enfermedades, Ministerio De Salud Del Per\u00fa. An\u00e1lisis De Situaci\u00f3n De Salud Del Per\u00fa, 2021. Lima: CDC-MINSA; 2023. Accessed 23 Dec 2023."},{"issue":"1","key":"12219_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.25176\/RFMH.v20i1.2657","volume":"20","author":"JA De La Cruz-Vargas","year":"2020","unstructured":"De La Cruz-Vargas JA, Ramos W, Chanduv\u00ed W, Espinoza R, Guerrero N, Loayza-Castro J, et al. Feasibility study to evaluate the proportion of cancer attributable to modificable risk factors in Peru and Latin America. Rev Fac Med Hum. 2020;20(1):114\u201322. https:\/\/doi.org\/10.25176\/RFMH.v20i1.2657","journal-title":"Rev Fac Med Hum"},{"key":"12219_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10412-9","volume":"21","author":"HS Teh","year":"2021","unstructured":"Teh HS, Woon YL. Burden of cancers attributable to modifiable risk factors in Malaysia. BMC Public Health. 2021;21:1\u201310.","journal-title":"BMC Public Health"},{"issue":"1","key":"12219_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21440","volume":"68","author":"F Islami","year":"2018","unstructured":"Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31\u201354.","journal-title":"CA Cancer J Clin"},{"key":"12219_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ypmed.2019.03.007","volume":"122","author":"DR Brenner","year":"2019","unstructured":"Brenner DR, Friedenreich CM, Ruan Y, Poirier AE, Walter SD, King WD, et al. The burden of cancer attributable to modifiable risk factors in Canada: methods overview. Prev Med. 2019;122:3\u20138.","journal-title":"Prev Med"},{"issue":"8","key":"12219_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","volume":"118","author":"KF Brown","year":"2018","unstructured":"Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130\u201341. https:\/\/doi.org\/10.1038\/s41416-018-0029-6","journal-title":"Br J Cancer"},{"issue":"10","key":"12219_CR13","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/annonc\/mdx342","volume":"28","author":"F Islami","year":"2017","unstructured":"Islami F, Chen W, Yu XQ, Lortet-Tieulent J, Zheng R, Flanders WD, et al. Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. Ann Oncol. 2017;28(10):2567\u201374. https:\/\/doi.org\/10.1093\/annonc\/mdx342","journal-title":"Ann Oncol"},{"issue":"1","key":"12219_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.35772\/ghm.2021.01037","volume":"4","author":"M Inoue","year":"2022","unstructured":"Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, et al. Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med. 2022;4(1):26\u201336. https:\/\/doi.org\/10.35772\/ghm.2021.01037","journal-title":"Glob Health Med"},{"issue":"3","key":"12219_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ijc.32284","volume":"146","author":"I Kulh\u00e1nov\u00e1","year":"2020","unstructured":"Kulh\u00e1nov\u00e1 I, Znaor A, Shield KD, Arnold M, Vignat J, Charafeddine M, et al. Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region. Int J Cancer. 2020;146(3):646\u201356. https:\/\/doi.org\/10.1002\/ijc.32284","journal-title":"Int J Cancer"},{"issue":"2","key":"12219_CR16","doi-asserted-by":"publisher","first-page":"e0148761","DOI":"10.1371\/journal.pone.0148761","volume":"11","author":"G Azevedo e Silva","year":"2016","unstructured":"Azevedo e Silva G, de Moura L, Curado MP, Gomes FS, Otero U, Rezende LFM, et al. The fraction of cancer attributable to ways of life, infections, occupation, and environmental agents in Brazil in 2020. PLoS ONE. 2016;11(2):e0148761. https:\/\/doi.org\/10.1371\/journal.pone.0148761","journal-title":"PLoS ONE"},{"key":"12219_CR17","doi-asserted-by":"publisher","unstructured":"Pichon-Riviere A, Bardach A, Rodr\u00edguez Cairoli F, Casarini A, Espinola N, Perelli L, et al. Health, economic and social burden of tobacco in Latin America and the expected gains of fully implementing taxes, plain packaging, advertising bans and smoke-free environments control measures: a modelling study. Tob Control. 2023:tc\u20132022\u2013057618. https:\/\/doi.org\/10.1136\/tc-2022-057618","DOI":"10.1136\/tc-2022-057618"},{"issue":"2","key":"12219_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.31557\/APJCP.2022.23.2.435","volume":"23","author":"JS Torres-Roman","year":"2022","unstructured":"Torres-Roman JS, Valcarcel B, Martinez-Herrera JF, Bazalar-Palacios J, La Vecchia C, Raez LE. Mortality trends for lung cancer and smoking prevalence in Peru. Asian Pac J cancer Prevention: APJCP. 2022;23(2):435. https:\/\/doi.org\/10.31557\/APJCP.2022.23.2.435","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"12219_CR19","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.canep.2023.102485","volume":"87","author":"JS Torres-Roman","year":"2023","unstructured":"Torres-Roman JS, Julca-Mar\u00edn D, Ticona-Ti\u00f1a D, Quispe-Vicu\u00f1a C, Bazalar-Palacios J, De La Cruz-Ku G, et al. Trends in gastric cancer mortality 2005\u20132020 in Peru and its geographical areas: a joinpoint regression analysis. Cancer Epidemiol. 2023;87:102485. https:\/\/doi.org\/10.1016\/j.canep.2023.102485","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"12219_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12894-023-01208-7","volume":"23","author":"JS Torres-Roman","year":"2023","unstructured":"Torres-Roman JS, De la Cruz-Ku G, Ju\u00e1rez-Leon V, Calder\u00f3n-Solano D, Bazalar-Palacios J, Vecchia CL, et al. Mortality trends and geographic distribution of kidney cancer in Peru: a secondary analysis. BMC Urol. 2023;23(1):51. https:\/\/doi.org\/10.1186\/s12894-023-01208-7","journal-title":"BMC Urol"},{"key":"12219_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10274-1","volume":"21","author":"JS Torres-Roman","year":"2021","unstructured":"Torres-Roman JS, Ronceros-Cardenas L, Valcarcel B, Arce-Huamani MA, Bazalar-Palacios J, Ybaseta-Medina J, et al. Cervical cancer mortality in Peru: regional trend analysis from 2008\u20132017. BMC Public Health. 2021;21:1\u201310. https:\/\/doi.org\/10.1186\/s12889-021-10274-1","journal-title":"BMC Public Health"},{"key":"12219_CR22","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.canep.2020.101791","volume":"68","author":"JS Torres-Roman","year":"2020","unstructured":"Torres-Roman JS, Gomez-Rubio V, Sanchez-Trujillo L, Delgado-Rosas E, Puche-Vergara F, Sanz-Anquela JM, et al. Geographic study of mortality due to mesothelioma in Peru and its evolution. Cancer Epidemiol. 2020;68:101791. https:\/\/doi.org\/10.1016\/j.canep.2020.101791","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"12219_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12885-020-07187-4","volume":"20","author":"LFM Rezende","year":"2020","unstructured":"Rezende LFM, Murata E, Giannichi B, Tomita LY, Wagner GA, Sanchez ZM, et al. Cancer cases and deaths attributable to lifestyle risk factors in Chile. BMC Cancer. 2020;20(1):693. https:\/\/doi.org\/10.1186\/s12885-020-07187-4","journal-title":"BMC Cancer"},{"issue":"10352","key":"12219_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"GBD 2019 Cancer Risk Factors Collaborators","year":"2022","unstructured":"GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6","journal-title":"Lancet"},{"issue":"S2","key":"12219_CR25","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/bjc.2011.474","volume":"105","author":"DM Parkin","year":"2011","unstructured":"Parkin DM. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(S2):S2\u20135. https:\/\/doi.org\/10.1038\/bjc.2011.474","journal-title":"Br J Cancer"},{"issue":"6","key":"12219_CR26","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/annonc\/mdq592","volume":"22","author":"A Shin","year":"2011","unstructured":"Shin A, Park S, Shin HR, Park EH, Park SK, Oh JK, et al. Population attributable fraction of infection-related cancers in Korea. Ann Oncol. 2011;22(6):1435\u201342. https:\/\/doi.org\/10.1093\/annonc\/mdq592","journal-title":"Ann Oncol"},{"key":"12219_CR27","unstructured":"Arnold M, Lam F, Ervik M, Soerjomataram I. Cancers attributable to UV radiation. Lyon, France: International Agency for Research on Cancer; 2018. https:\/\/gco.iarc.fr\/causes\/uv"},{"issue":"5","key":"12219_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1753-6405.12471","volume":"39","author":"DC Whiteman","year":"2015","unstructured":"Whiteman DC, Webb PM, Green AC, Neale RE, Fritschi L, Bain CJ, et al. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N Z J Public Health. 2015;39(5):477\u201384. https:\/\/doi.org\/10.1111\/1753-6405.12471","journal-title":"Aust N Z J Public Health"},{"key":"12219_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ypmed.2019.04.007","volume":"122","author":"AE Poirier","year":"2019","unstructured":"Poirier AE, Ruan Y, Volesky KD, King WD, O\u2019Sullivan DE, Gogna P, et al. The current and future burden of cancer attributable to modifiable risk factors in Canada: summary of results. Prev Med. 2019;122:140\u20137. https:\/\/doi.org\/10.1016\/j.ypmed.2019.04.007","journal-title":"Prev Med"},{"issue":"1","key":"12219_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","volume":"39","author":"RM Feng","year":"2019","unstructured":"Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond). 2019;39(1):22. https:\/\/doi.org\/10.1186\/s40880-019-0368-6","journal-title":"Cancer Commun (Lond)"},{"issue":"6101","key":"12219_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.1223466","volume":"337","author":"IC Bygbjerg","year":"2012","unstructured":"Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science. 2012;337(6101):1499\u2013501. https:\/\/doi.org\/10.1126\/science.1223466","journal-title":"Science"},{"issue":"3","key":"12219_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.trstmh.2005.07.021","volume":"100","author":"A Boutayeb","year":"2006","unstructured":"Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100(3):191\u20139. https:\/\/doi.org\/10.1016\/j.trstmh.2005.07.021","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"12219_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/carcin\/bgp263","volume":"31","author":"MJ Thun","year":"2010","unstructured":"Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100\u201310. https:\/\/doi.org\/10.1093\/carcin\/bgp263","journal-title":"Carcinogenesis"},{"issue":"1","key":"12219_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.25176\/RFMH.v21i1.3592","volume":"21","author":"D Venegas-Ojeda","year":"2021","unstructured":"Venegas-Ojeda D, Ag\u00fcero-Palacios YD. Gastric cancer mortality rate trend in Peru: segmented regression model from 1995 to 2013. Rev Fac Med Hum. 2021;21(1):28\u201339. https:\/\/doi.org\/10.25176\/RFMH.v21i1.3592","journal-title":"Rev Fac Med Hum"},{"issue":"5","key":"12219_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1590\/S1135-57272003000500009","volume":"77","author":"J Szot Meza","year":"2003","unstructured":"Szot Meza J. Demographic-epidemiologic transition in Chile, 1960\u20132001. Rev Esp Salud Publica. 2003;77(5):605\u201313.","journal-title":"Rev Esp Salud Publica"},{"key":"12219_CR36","unstructured":"Turra C, Fernandes F. La transici\u00f3n demogr\u00e1fica: oportunidades y desaf\u00edos en la senda hacia el logro de los Objetivos de Desarrollo Sostenible en Am\u00e9rica Latina y el Caribe, Documentos de Proyectos (LC\/TS.2020\/105). Santiago, Comisi\u00f3n Econ\u00f3mica para Am\u00e9rica Latina y el Caribe (CEPAL); 2021. https:\/\/www.cepal.org\/es\/publicaciones\/46805-la-transicion-demografica-oportunidades-desafios-la-senda-logro-objetivos"},{"issue":"2","key":"12219_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.31557\/APJCP.2022.23.2.435","volume":"23","author":"JS Torres-Roman","year":"2022","unstructured":"Torres-Roman JS, Valcarcel B, Martinez-Herrera JF, Bazalar-Palacios J, La Vecchia C, Raez LE. Mortality trends for lung cancer and smoking prevalence in Peru. Asian Pac J Cancer Prev. 2022;23(2):435\u201343. https:\/\/doi.org\/10.31557\/APJCP.2022.23.2.435","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"12219_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/pcmr.12885","volume":"34","author":"P Basurto-Lozada","year":"2021","unstructured":"Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, V\u00e1zquez-Cruz ME, Garcia-Salinas OI, \u00c1lvarez-Cano A, et al. Acral lentiginous melanoma: basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021;34(1):59\u201371. https:\/\/doi.org\/10.1111\/pcmr.12885","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"12219_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12865-018-0253-0","volume":"19","author":"A Palladini","year":"2018","unstructured":"Palladini A, Landuzzi L, Lollini PL, Nanni P. Cancer immunoprevention: from mice to early clinical trials. BMC Immunol. 2018;19(1):16. https:\/\/doi.org\/10.1186\/s12865-018-0253-0","journal-title":"BMC Immunol"},{"issue":"13","key":"12219_CR40","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2174\/138945011798184146","volume":"12","author":"PL Lollini","year":"2011","unstructured":"Lollini PL, Nicoletti G, Landuzzi L, Cavallo F, Forni G, De Giovanni C, et al. Vaccines and other immunological approaches for cancer immunoprevention. Curr Drug Targets. 2011;12(13):1957\u201373. https:\/\/doi.org\/10.2174\/138945011798184146","journal-title":"Curr Drug Targets"},{"issue":"11","key":"12219_CR41","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.31557\/APJCP.2019.20.11.3193","volume":"20","author":"M Castillo","year":"2019","unstructured":"Castillo M, Bernabe L, Castaneda CA, Chavez I, Ruiz E, Barreda F, et al. Helicobacter Pylori detected in tap water of Peruvian patients with gastric Cancer. Asian Pac J Cancer Prev. 2019;20(11):3193\u20136. https:\/\/doi.org\/10.31557\/APJCP.2019.20.11.3193","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"12219_CR42","doi-asserted-by":"publisher","first-page":"e0128491","DOI":"10.1371\/journal.pone.0128491","volume":"10","author":"L Eichelberger","year":"2015","unstructured":"Eichelberger L, Murphy G, Etemadi A, Abnet CC, Islami F, Shakeri R, et al. Risk of gastric cancer by water source: evidence from the Golestan case-control study. PLoS ONE. 2015;10(5):e0128491. https:\/\/doi.org\/10.1371\/journal.pone.0128491","journal-title":"PLoS ONE"},{"issue":"8756","key":"12219_CR43","first-page":"1503","volume":"337","author":"PD Klein","year":"1991","unstructured":"Klein PD, Graham DY, Gaillour A, Opekun AR, Smith EO. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointest Physiol Working Group Lancet. 1991;337(8756):1503\u20136.","journal-title":"Gastrointest Physiol Working Group Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12219-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:10:54Z","timestamp":1721945454000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12219-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12219"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12219-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"From an ethical standpoint, this study did not imply risks to individuals, as it used aggregated prevalence data from population surveys, relative risks from metanalysis and scientific journal articles, along with IARC cancer incidence and mortality estimates for Peru, thus not requiring an informed consent. Additionally, the study received approval from the Research Ethics Committee from the Medical School of Ricardo Palma University (Expedited Review: PI-019-2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}